Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,755.20
(
-1.56%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
107.79
(
1.13%
)
Bitcoin
71,091.34
(
-0.21%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: biomaven0 post# 129577

Thursday, 10/27/2011 10:51:31 AM

Thursday, October 27, 2011 10:51:31 AM

Post# of 257257

INCY made a big deal of their compound not hitting JAK3, but I'm not really seeing any evidence yet to support their theory.



Although maybe the incidence of infections in the 12-week VRTX trial is some preliminary support for INCY's theory.

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now